COMMUNIQUÉS West-GlobeNewswire

EHNAC Announces Development of New Trusted Exchange Accreditation Program

15/05/2018 - 15:00

Accreditation program to align with 21st Century Cures Act, leverage existing frameworks and best practices while supporting blockchain, GDPR, cloud, and other underlying enabling technologies FARMINGTON, Conn., May 15 [...]

Protech Home Medical Releases Second Quarter Financial Results

15/05/2018 - 15:00

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, May 15, 2018 (GLOBE NEWSWIRE) -- Protech Home [...]

BioAdaptives, Inc Names Dr. James Rouse as President

15/05/2018 - 15:00

LAS VEGAS, May 15, 2018 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC PINK:BDPT) announced Dr. James Rouse has been appointed to the board of Directors and accepted the position of President. He will start serving in both [...]

CV Sciences, Inc. Reports First Quarter 2018 Financial Results

15/05/2018 - 14:45

- Record Quarter on All Key Financial Performance Metrics Including 114% Increase in Sales Year-Over-Year and Double Digit Sequential Sales Growth - Management to Host Webcast on May 15, 2018 to Discuss Q1 2018 [...]

Abattis Adds Significant Strength to its Board and Leadership Team

15/05/2018 - 14:34

VANCOUVER, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce the appointments of Kent McParland, Brazos Minshew, [...]

Onconova Therapeutics, Inc. Reports Business Highlights and Financial Results for First Quarter 2018

15/05/2018 - 14:30

NEWTOWN, Pa., May 15, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat [...]

Acology 10Q Confirms Revenue and Net Income Surge: EU Patent Next

15/05/2018 - 14:30

CORONA, Calif., May 15, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (ACOL-OTCMARKETS) released its’ 10Q, confirming that business continues to steadily grow and sustaining the expansion of the company that began more than 18 [...]

Moleculin Biotech, Inc. Reports Financial Results for the First Quarter Ended March 31, 2018

15/05/2018 - 14:30

HOUSTON, May 15, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ: MBRX ) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]

Micron Solutions, Inc. Reports 2018 First Quarter Results

15/05/2018 - 14:17

FITCHBURG, Mass., May 15, 2018 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American:MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]

Novan Provides Update on SB414 Inflammatory Skin Disease Development Program

15/05/2018 - 14:10

SB414 – Nitric Oxide-Releasing Cream – Safe and Well-Tolerated in Psoriasis Phase 1b Trial Preclinical Data with SB414 Targeting Key Inflammatory Cytokines IL-4 and IL-13 in Atopic Dermatitis to be presented at [...]

Quotient Limited to Report Fourth Quarter and Fiscal Full Year 2018 Financial Results and Host Conference Call

15/05/2018 - 14:00

JERSEY, Channel Islands, May 15, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and fiscal full year [...]

Aeglea BioTherapeutics to Present at UBS Global Healthcare Conference

15/05/2018 - 14:00

Company to Webcast Presentation on Tuesday, May 22 at 8:30 a.m. ET AUSTIN, Texas, May 15, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a clinical-stage biotechnology company that designs and [...]

Neos Therapeutics to Present at the UBS Global Healthcare Conference

15/05/2018 - 14:00

DALLAS and FORT WORTH, Texas, May 15, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS ), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) [...]

Daré Bioscience, Inc. Announces Trial Initiation for Ovaprene® Non-Hormonal Monthly Contraceptive Candidate

15/05/2018 - 14:00

SAN DIEGO, May 15, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a clinical-stage, women’s biopharmaceutical company focused on women’s sexual and reproductive health, announced today the initiation of [...]

EndoLogic Announces FDA Accepts Cardiac Safety Trial for Renzapride in Patients with Gastroparesis

15/05/2018 - 14:00

Study demonstrates no evidence of QTc prolongation EndoLogic remains on plan to initiate 12-week renzapride Phase 2 trial pending collaboration with a development partner CLIFTON, N.J., May 15, 2018 (GLOBE NEWSWIRE) -- [...]

SteadyMed Provides Corporate Update and Reports First Quarter 2018 Financial Results

15/05/2018 - 14:00

SAN RAMON, Calif., May 15, 2018 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq: STDY ), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with [...]

Fortress Biotech Appoints Michael G. King, Jr. as Entrepreneur in Residence

15/05/2018 - 14:00

NEW YORK, May 15, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO ) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]

Cambrex Completes Pilot Plant Expansion at its High Point, NC Facility

15/05/2018 - 14:00

Work Underway on New $24 Million High Potency Plant at Charles City, Iowa EAST RUTHERFORD, N.J., May 15, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), the leading manufacturer of small molecule innovator [...]

Rexahn Phase 2a Combination Study of RX-3117 and Abraxane® in First-line Metastatic Pancreatic Cancer Patients Advances to Second Stage

15/05/2018 - 14:00

Routine Safety Monitoring Committee Review Confirmed No Dose Reductions Necessary ROCKVILLE, Md., May 15, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical-stage biopharmaceutical [...]